Bestatin inhibits the development of cutaneous melanoma by inhibiting the expression of LTA4H
Front Immunol. 2026 Jul 28;17:1901844. doi: 10.3389/fimmu.2026.1901844.
Article
Aug 12, 2026
Consortium publication
No